1. Home
  2. FEAM vs IMMX Comparison

FEAM vs IMMX Comparison

Compare FEAM & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$3.55

Market Cap

89.1M

Sector

Industrials

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$5.73

Market Cap

306.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
IMMX
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.1M
306.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FEAM
IMMX
Price
$3.55
$5.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$8.13
$12.00
AVG Volume (30 Days)
85.5K
1.4M
Earning Date
02-12-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$500.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$1.34
52 Week High
$24.84
$7.73

Technical Indicators

Market Signals
Indicator
FEAM
IMMX
Relative Strength Index (RSI) 41.95 56.94
Support Level $3.21 $5.46
Resistance Level $3.70 $6.09
Average True Range (ATR) 0.30 0.74
MACD -0.02 -0.12
Stochastic Oscillator 28.00 38.39

Price Performance

Historical Comparison
FEAM
IMMX

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: